Bill > HR6133

This bill, the Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018, aims to deter opioid abuse and addiction by developing high-quality, evidence-based opioid analgesic (pain medication) prescribing guidelines. The bill requires the Commissioner of Food and Drugs to conduct a study and develop these guidelines in areas where they do not currently exist or are not redundant of existing guidelines. The bill also mandates that the Commissioner seek public input and regularly update the study and guidelines. Additionally, the bill requires the Commissioner to ensure that any regulations, guidance, and policies related to opioid prescribing practices issued after the bill's enactment are based on evidence-based practices, and that any guidelines or recommendations developed under the bill are accompanied by a clear statement that they are intended to inform clinical decision-making, not to be used by other parties to restrict, limit, delay, or deny coverage or access to legitimate medical prescriptions.

Business and Industry

https://www.congress.gov/bill/115th-congress/house-bill/6133/all-info